ANN ARBOR, Mich., Sept. 01, 2015 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB:KBLB) (“Company”), the leading developer of advanced spider silk based fibers, announced today that the Company have moved its corporate headquarters to a new location in Ann Arbor, Michigan.
The address of the new location is 2723 South State St., Suite 150 Ann Arbor, MI 48104. The new phone number will be 734-619-8066. All other contact information will remain the same.
“We are pleased to announce today that Kraig Labs has moved our corporate office to Ann Arbor. Ann Arbor has an exceptional history of developing and attracting some of the brightest minds and most transformative companies in genetic engineering,” said Founder and CEO Kim Thompson. “This move gives us increased access to a talented pool of scientists and technicians with a strong culture of innovation. We look forward to continued growth of Kraig Labs and I believe this new headquarters and its access to a high skilled workforce will play an important role in that progress.”
"Companies like Kraig Labs know that this region's talented workforce is a competitive advantage," said Paul Krutko, president and CEO of Ann Arbor SPARK. "The strong cluster of biotech and life science companies in Ann Arbor attracts and nurtures businesses like Kraig Labs, which in turn cultivates the talent pool here. It's exciting to welcome this growing business to the region."
About Kraig Biocraft Laboratories, Inc.
Kraig Biocraft Laboratories, Inc. (www.KraigLabs.com), a fully reporting biotechnology company is the leading developer of genetically engineered spider silk based fiber technologies. The Company has achieved a series of scientific breakthroughs in the area of spider silk technology with implications for the global textile industry.
Cautionary Statement Regarding Forward Looking Information
Statements in this press release about the Company’s future and expectations other than historical facts are “forward-looking statements.” These statements are made on the basis of management’s current views and assumptions. As a result, there can be no assurance that management’s expectations will necessarily come to pass. These forward-looking statements generally can be identified by phrases such as “believes,” “plans,” “expects,” “anticipates,” “foresees,” “estimated,” “hopes,” “if,” “develops,” “researching,” “research,” “pilot,” “potential,” “could” or other words or phrases of similar import. Forward looking statements include descriptions of the Company’s business strategy, outlook, objectives, plans, intentions and goals. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements.
This press release does not constitute an offer to sell or the solicitation of an offer to buy any security.
Ben Hansel, Hansel Capital, LLC. (720) 288-8495 ir@KraigLabs.com
Source:Kraig Biocraft Laboratories, Inc